IBDEI1V4 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,29743,1,3,0)
;;=3^Cocaine Use DO,Mild,In Remiss
;;^UTILITY(U,$J,358.3,29743,1,4,0)
;;=4^F14.11
;;^UTILITY(U,$J,358.3,29743,2)
;;=^268249
;;^UTILITY(U,$J,358.3,29744,0)
;;=F15.21^^118^1502^34
;;^UTILITY(U,$J,358.3,29744,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29744,1,3,0)
;;=3^Oth Stimulant Dependence,Mod/Sev,In Remission
;;^UTILITY(U,$J,358.3,29744,1,4,0)
;;=4^F15.21
;;^UTILITY(U,$J,358.3,29744,2)
;;=^5003296
;;^UTILITY(U,$J,358.3,29745,0)
;;=Z91.120^^118^1503^1
;;^UTILITY(U,$J,358.3,29745,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29745,1,3,0)
;;=3^Intentional Underdosing d/t Financial Hardship
;;^UTILITY(U,$J,358.3,29745,1,4,0)
;;=4^Z91.120
;;^UTILITY(U,$J,358.3,29745,2)
;;=^5063612
;;^UTILITY(U,$J,358.3,29746,0)
;;=Z91.128^^118^1503^2
;;^UTILITY(U,$J,358.3,29746,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29746,1,3,0)
;;=3^Intentional Underdosing,Other Reasons
;;^UTILITY(U,$J,358.3,29746,1,4,0)
;;=4^Z91.128
;;^UTILITY(U,$J,358.3,29746,2)
;;=^5063613
;;^UTILITY(U,$J,358.3,29747,0)
;;=Z91.130^^118^1503^15
;;^UTILITY(U,$J,358.3,29747,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29747,1,3,0)
;;=3^Unintented Underdosing d/t Age-Related Disability
;;^UTILITY(U,$J,358.3,29747,1,4,0)
;;=4^Z91.130
;;^UTILITY(U,$J,358.3,29747,2)
;;=^5063614
;;^UTILITY(U,$J,358.3,29748,0)
;;=Z91.138^^118^1503^16
;;^UTILITY(U,$J,358.3,29748,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29748,1,3,0)
;;=3^Unintented Underdosing,Other Reasons
;;^UTILITY(U,$J,358.3,29748,1,4,0)
;;=4^Z91.138
;;^UTILITY(U,$J,358.3,29748,2)
;;=^5063615
;;^UTILITY(U,$J,358.3,29749,0)
;;=T38.3X6A^^118^1503^3
;;^UTILITY(U,$J,358.3,29749,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29749,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Init Encntr
;;^UTILITY(U,$J,358.3,29749,1,4,0)
;;=4^T38.3X6A
;;^UTILITY(U,$J,358.3,29749,2)
;;=^5049649
;;^UTILITY(U,$J,358.3,29750,0)
;;=T38.3X6S^^118^1503^4
;;^UTILITY(U,$J,358.3,29750,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29750,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
;;^UTILITY(U,$J,358.3,29750,1,4,0)
;;=4^T38.3X6S
;;^UTILITY(U,$J,358.3,29750,2)
;;=^5049651
;;^UTILITY(U,$J,358.3,29751,0)
;;=T38.3X6D^^118^1503^5
;;^UTILITY(U,$J,358.3,29751,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29751,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
;;^UTILITY(U,$J,358.3,29751,1,4,0)
;;=4^T38.3X6D
;;^UTILITY(U,$J,358.3,29751,2)
;;=^5049650
;;^UTILITY(U,$J,358.3,29752,0)
;;=T46.5X6A^^118^1503^9
;;^UTILITY(U,$J,358.3,29752,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29752,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
;;^UTILITY(U,$J,358.3,29752,1,4,0)
;;=4^T46.5X6A
;;^UTILITY(U,$J,358.3,29752,2)
;;=^5051353
;;^UTILITY(U,$J,358.3,29753,0)
;;=T46.5X6D^^118^1503^10
;;^UTILITY(U,$J,358.3,29753,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29753,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
;;^UTILITY(U,$J,358.3,29753,1,4,0)
;;=4^T46.5X6D
;;^UTILITY(U,$J,358.3,29753,2)
;;=^5051354
;;^UTILITY(U,$J,358.3,29754,0)
;;=T46.5X6S^^118^1503^11
;;^UTILITY(U,$J,358.3,29754,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,29754,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Sequela
;;^UTILITY(U,$J,358.3,29754,1,4,0)
;;=4^T46.5X6S
;;^UTILITY(U,$J,358.3,29754,2)
;;=^5051355
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1V4 3774 printed Apr 09, 2024@21:49:31 Page 2
IBDEI1V4 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,29743,1,3,0)
+2 ;;=3^Cocaine Use DO,Mild,In Remiss
+3 ;;^UTILITY(U,$J,358.3,29743,1,4,0)
+4 ;;=4^F14.11
+5 ;;^UTILITY(U,$J,358.3,29743,2)
+6 ;;=^268249
+7 ;;^UTILITY(U,$J,358.3,29744,0)
+8 ;;=F15.21^^118^1502^34
+9 ;;^UTILITY(U,$J,358.3,29744,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,29744,1,3,0)
+12 ;;=3^Oth Stimulant Dependence,Mod/Sev,In Remission
+13 ;;^UTILITY(U,$J,358.3,29744,1,4,0)
+14 ;;=4^F15.21
+15 ;;^UTILITY(U,$J,358.3,29744,2)
+16 ;;=^5003296
+17 ;;^UTILITY(U,$J,358.3,29745,0)
+18 ;;=Z91.120^^118^1503^1
+19 ;;^UTILITY(U,$J,358.3,29745,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,29745,1,3,0)
+22 ;;=3^Intentional Underdosing d/t Financial Hardship
+23 ;;^UTILITY(U,$J,358.3,29745,1,4,0)
+24 ;;=4^Z91.120
+25 ;;^UTILITY(U,$J,358.3,29745,2)
+26 ;;=^5063612
+27 ;;^UTILITY(U,$J,358.3,29746,0)
+28 ;;=Z91.128^^118^1503^2
+29 ;;^UTILITY(U,$J,358.3,29746,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,29746,1,3,0)
+32 ;;=3^Intentional Underdosing,Other Reasons
+33 ;;^UTILITY(U,$J,358.3,29746,1,4,0)
+34 ;;=4^Z91.128
+35 ;;^UTILITY(U,$J,358.3,29746,2)
+36 ;;=^5063613
+37 ;;^UTILITY(U,$J,358.3,29747,0)
+38 ;;=Z91.130^^118^1503^15
+39 ;;^UTILITY(U,$J,358.3,29747,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,29747,1,3,0)
+42 ;;=3^Unintented Underdosing d/t Age-Related Disability
+43 ;;^UTILITY(U,$J,358.3,29747,1,4,0)
+44 ;;=4^Z91.130
+45 ;;^UTILITY(U,$J,358.3,29747,2)
+46 ;;=^5063614
+47 ;;^UTILITY(U,$J,358.3,29748,0)
+48 ;;=Z91.138^^118^1503^16
+49 ;;^UTILITY(U,$J,358.3,29748,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,29748,1,3,0)
+52 ;;=3^Unintented Underdosing,Other Reasons
+53 ;;^UTILITY(U,$J,358.3,29748,1,4,0)
+54 ;;=4^Z91.138
+55 ;;^UTILITY(U,$J,358.3,29748,2)
+56 ;;=^5063615
+57 ;;^UTILITY(U,$J,358.3,29749,0)
+58 ;;=T38.3X6A^^118^1503^3
+59 ;;^UTILITY(U,$J,358.3,29749,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,29749,1,3,0)
+62 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Init Encntr
+63 ;;^UTILITY(U,$J,358.3,29749,1,4,0)
+64 ;;=4^T38.3X6A
+65 ;;^UTILITY(U,$J,358.3,29749,2)
+66 ;;=^5049649
+67 ;;^UTILITY(U,$J,358.3,29750,0)
+68 ;;=T38.3X6S^^118^1503^4
+69 ;;^UTILITY(U,$J,358.3,29750,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,29750,1,3,0)
+72 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
+73 ;;^UTILITY(U,$J,358.3,29750,1,4,0)
+74 ;;=4^T38.3X6S
+75 ;;^UTILITY(U,$J,358.3,29750,2)
+76 ;;=^5049651
+77 ;;^UTILITY(U,$J,358.3,29751,0)
+78 ;;=T38.3X6D^^118^1503^5
+79 ;;^UTILITY(U,$J,358.3,29751,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,29751,1,3,0)
+82 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
+83 ;;^UTILITY(U,$J,358.3,29751,1,4,0)
+84 ;;=4^T38.3X6D
+85 ;;^UTILITY(U,$J,358.3,29751,2)
+86 ;;=^5049650
+87 ;;^UTILITY(U,$J,358.3,29752,0)
+88 ;;=T46.5X6A^^118^1503^9
+89 ;;^UTILITY(U,$J,358.3,29752,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,29752,1,3,0)
+92 ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
+93 ;;^UTILITY(U,$J,358.3,29752,1,4,0)
+94 ;;=4^T46.5X6A
+95 ;;^UTILITY(U,$J,358.3,29752,2)
+96 ;;=^5051353
+97 ;;^UTILITY(U,$J,358.3,29753,0)
+98 ;;=T46.5X6D^^118^1503^10
+99 ;;^UTILITY(U,$J,358.3,29753,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,29753,1,3,0)
+102 ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
+103 ;;^UTILITY(U,$J,358.3,29753,1,4,0)
+104 ;;=4^T46.5X6D
+105 ;;^UTILITY(U,$J,358.3,29753,2)
+106 ;;=^5051354
+107 ;;^UTILITY(U,$J,358.3,29754,0)
+108 ;;=T46.5X6S^^118^1503^11
+109 ;;^UTILITY(U,$J,358.3,29754,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,29754,1,3,0)
+112 ;;=3^Underdosing of Antihypertensive Drugs,Sequela
+113 ;;^UTILITY(U,$J,358.3,29754,1,4,0)
+114 ;;=4^T46.5X6S
+115 ;;^UTILITY(U,$J,358.3,29754,2)
+116 ;;=^5051355
